赛默飞世尔科技:生物制药复苏与市场份额增长支撑上涨空间(纽约证券交易所代码:TMO)

· seekingalpha.com

赛默飞世尔评级为买入:有机增长加速、利润率提升和收购增加制药/生物技术敞口。点击了解更多关于TMO股票的信息。

Thermo Fisher Scientific's ( TMO ) end markets have begun to rebound from a relatively muted period with organic revenue growth accelerating to 5% in Q2 2026. P...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI